Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00134368 · ClinicalTrials.gov registry record · Phase 2
Study of the Efficacy and Safety of Etanercept in Adults With Vitiligo
A Phase 2 study, sponsored by University of Medicine and Dentistry of New Jersey.
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT00134368 is a Phase 2 study that has completed, run by University of Medicine and Dentistry of New Jersey. The registered enrollment target is 40 participants.
The verdict
NCT00134368, a Phase 2 study, has completed, sponsored by University of Medicine and Dentistry of New Jersey.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the efficacy and safety of etanercept in adults with vitiligo.
Interventions
- DRUG Etanercept
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2003-11 |
| Est. Completion | 2007-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00134368
The ClinicalTrials.gov registry entry for NCT00134368 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Medicine and Dentistry of New Jersey, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Etanercept is the first listed.
NCT00134368 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00134368 about?
NCT00134368 is a clinical study titled "Study of the Efficacy and Safety of Etanercept in Adults With Vitiligo". The purpose of this study is to investigate the efficacy and safety of etanercept in adults with vitiligo.
What is the current status of trial NCT00134368?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2003-11. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00134368?
The interventions under investigation include: Etanercept (DRUG).
Who is sponsoring clinical trial NCT00134368?
This trial is sponsored by University of Medicine and Dentistry of New Jersey, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.